Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2026-03-09 @ 1:57 AM
Study NCT ID:
NCT00579527
Status:
COMPLETED
Last Update Posted:
2022-03-25
First Post:
2007-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I/II Thymus Transplantation With Immunosuppression #950
Sponsor:
Sumitomo Pharma Switzerland GmbH
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | DiGeorge Anomaly | View |
| None | Thymus Transplantation | View |
| None | DiGeorge Syndrome | View |
| None | Athymia | View |
| None | Parathyroid Transplantation | View |
| None | Hypocalcemia | View |
| None | Hypoparathyroidism | View |
| None | Low T cell numbers | View |
| None | Immunoreconstitution | View |
| None | Immunodeficiency | View |
| None | Complete DiGeorge Anomaly | View |
| None | Complete Atypical DiGeorge Anomaly | View |
| None | Complete DiGeorge Syndrome | View |
| None | Complete Atypical DiGeorge Syndrome | View |
| None | Cultured Thymus Tissue Implantation (CTTI) | View |